Revumenib Impurity 9 | CAS 1023301-84-9 - Request Quote
Revumenib Impurity 9
| SZ CAT No: | SZ-R086010 |
| CAS No | 1023301-84-9 |
| Mol.F. | C12H22N2O2 : HCl |
| Mol.Wt. | 226.3 : 36.5 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 896464-16-7 (free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Revumenib Impurity 9 is chemically Tert-butyl 2,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride. Revumenib Impurity 9 is supplied with detailed characterization data compliant with regulatory guideline. Revumenib Impurity 9 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Revumenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1023301-84-9
Purchase 1023301-84-9
Order 1023301-84-9
Enquire 1023301-84-9
price of 1023301-84-9
1023301-84-9 Supplier
1023301-84-9 Manufacturer
1023301-84-9 Exporter
buy high quality Revumenib Impurity 9
Purchase Revumenib Impurity 9
Revumenib Impurity 9 suppliers
Revumenib Impurity 9 manufacturers
Revumenib Impurity 9 price
Order Revumenib Impurity 9
Enquire Revumenib Impurity 9
Revumenib Impurity 9 cost
Revumenib Impurity 9 Supplier
Revumenib Impurity 9 Distributor
Revumenib Impurity 9 for Method Validation
Revumenib Reference Standard
Revumenib Impurity 9 for ANDA Filing
Revumenib Impurity 9 for Forced Degradation Studies
Revumenib Impurity 9 Identification Standards
Revumenib Impurity 9 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.